Bovine Digital Dermatitis: How Treponema phagedenis Drives Cattle Lameness (and What to Do About It)

Lameness quietly drains profit from cattle operations, and bovine digital dermatitis (BDD) is one of the main reasons cows go lame. If you run dairy or beef cattle, you have probably already met the lesions. They show up as painful, ulcerative patches on the heels and between the toes, and they get worse fast in wet, muddy, crowded conditions. What happens under the skin is messier than it looks. A spiral-shaped bacterium called Treponema phagedenis now sits near the center of the story.

This piece covers what we actually know about T. phagedenis, how it fits into digital dermatitis, why lesions keep coming back, and what works for diagnosis, treatment, and keeping a herd clean.

What bovine digital dermatitis is

BDD is a contagious hoof infection and a leading cause of lameness in cattle around the world. It was first written up in Italy in 1974 and has since turned up across Europe, the Americas, Asia, Oceania, and Africa. Sick animals go lame, give less milk, breed worse, get culled earlier, and cost more to treat. The damage usually appears on the underside of the hind feet, near the interdigital cleft and the heel bulbs.

The frustrating part is that no single germ causes it. BDD is polymicrobial. Active lesions are packed with anaerobic bacteria, and treponemes, those slender corkscrew spirochetes, keep showing up. Three treponemal types link most consistently to BDD: T. phagedenis, T. medium, and T. pedis. T. phagedenis gets the most attention because it turns up so often in lesions and seems able to keep them alive and recurring.

Getting to know Treponema phagedenis

T. phagedenis is a Gram-negative, strictly anaerobic, motile spirochete. Like its relatives, it is thin and helical, with internal flagella that let it twist through thick gunk such as mucus, biofilms, and broken tissue. Under a microscope the cells run about 9 to 12 micrometers long and 0.2 to 0.25 micrometers wide, with a near-circular kink in the middle and gently coiled ends.

A few things matter if you ever try to grow or study it.

It is fussy about food. The bacterium is heterotrophic and ferments carbohydrates and amino acids. It grows well on fructose, glucose, maltose, mannitol, mannose, pectin, ribose, and soluble starch, but much more slowly on arabinose, cellobiose, galactose, or lactose.

It needs special supplements. Growth leans heavily on heat-inactivated fetal bovine serum, polypeptone, and yeast extract. Take those out and it stalls.

Its surface is diverse. The outer membrane carries proteins and lipoproteins such as PrrA, TmpA, Ttm, VpsA, VpsB, and some likely beta-barrel outer membrane proteins. Several of these are immunogenic and are now being looked at as vaccine candidates.

Put those traits together and you see why T. phagedenis is so comfortable in damaged, nutrient-rich skin. You also see why it is hard to culture and therefore hard to study with ordinary lab methods.

Where BDD shows up and how it moves

Evidence of BDD-associated treponemes now comes from more than 30 countries. Cattle are the main host, but treponemes have also turned up in sheep with foot lesions, donkeys with horn tumors, European bison, and wild elk and moose with hoof disease. One odd human case from China found T. phagedenis in cerebrospinal fluid, but genetic work placed it in a human lineage separate from the bovine strains in BDD. The real lesson is that related treponemes appear across species, yet the evidence does not show frequent jumping between them.

BDD spreads mostly through three routes. Infected and healthy cattle touch directly. The environment gets contaminated by wet, dirty walking surfaces. And tools move the bug around, especially hoof trimmers and knives. One study found BDD-associated treponemes can survive on hoof-trimming blades for two hours in open air. That single fact makes thorough cleaning between animals and between farms hard to argue against.

Risk rises with wet, muddy ground, poor hoof hygiene, overcrowding, hoof injuries, stress, possible zinc deficiency, and other infections. Some farms see seasonal peaks in humid periods, though the pattern depends on local climate and management.

How lesions progress

Veterinarians and herd managers usually score BDD with an M-stage system.

M0 is healthy skin, intact and not painful to press. M1 is early: small lesions under 2 cm, gray or red, rough, and painful. M2 is the acute phase, with lesions past 2 cm, ulceration, and cracks between the toes. M3 is healing, when a scab forms, the tissue hardens and browns, and pain fades. M4 is chronic, with hardened skin and gray-white or brown filamentous, crust-like growths that do not hurt to press. M4.1 is the chronic-active stage, where small new ulcers appear inside an old M4 lesion and often signal a slide back to M2.

The reason BDD never really goes away is that healing is often incomplete. Even in M3 and M4 stages that look calm, research shows inflammation stays high. A shared molecular signature appears in both acute and chronic lesions, with inflammatory genes switched on and the genes for skin-barrier keratin switched off. The IL-17F pathway in particular stays active, which points to ongoing tissue damage and slow wound repair. A lesion that looks healed can still be quietly inflamed and ready to flare.

T. phagedenis and T. pedis line up with more activity in apoptosis-related genes, while T. medium and T. pedis connect to changes in the cell skeleton and loss of cell adhesion. Those processes can break tissue down and help the bacteria move. T. phagedenis also pushes the host to make more of an antimicrobial peptide precursor called DEFB123, a hint of a distinct immune reaction inside the mixed community of the lesion.

What the immune system does, and why it usually loses

Cattle with BDD do fight back. Blood tests show animals with active lesions carry clearly higher levels of anti-T. phagedenis IgG than healthy controls, which confirms the animal recognizes the bacterium. Macrophages, the front-line immune cells, respond to T. phagedenis through an inflammasome pathway that releases IL-1beta, and those activated cells can hang around in lesions even after antibiotics.

But antibodies do not equal lasting protection. Immune responses to BDD antigens shift as the disease moves through stages, and they do not reliably block reinfection. That is a big part of why recurrence is the rule rather than the exception.

The bacterium may use antigenic variation as a trick. It can rearrange certain genes to change the proteins on its surface, which makes it harder for the immune system to lock onto a steady target. Two surface lipoproteins, VpsA and VpsB, sit near the known antigen PrrA, and changes in these genes, including repeat-number shifts in their regulatory regions, give a plausible mechanism for that evasion.

This is also why a vaccine keeps slipping out of reach. Several surface proteins are promising candidates, yet BDD’s polymicrobial nature, the genetic spread among treponeme isolates, our incomplete picture of what protective immunity even looks like, and the sheer difficulty of growing the organism all get in the way. No vaccine has been broadly validated for field use.

How BDD gets diagnosed

In the field, diagnosis still leans on clinical lesion staging with the M-score system. With the right microscope, you can see spirochetes directly under dark-field or phase-contrast settings, but that method is not very sensitive.

For research and more dependable detection, the toolkit has a few options. PCR, nested PCR, and qPCR pick up treponemal DNA with high sensitivity and can tell the different BDD-associated treponemal types apart. ELISA serology measures the animal’s antibody response. Fluorescence in situ hybridization, or FISH, is the reference method for seeing exactly where treponemes sit in the tissue, whether in the epidermis, at the dermal-epidermal junction, or deeper, which strongly suggests true tissue association instead of surface contamination. Pairing clinical M-stage scoring with PCR/qPCR and FISH gives a much truer picture than eyes alone.

Treatment and control

Managing BDD is less about curing one infection and more about running a sustained program across the herd.

Topical oxytetracycline has been used for years on individual lesions, especially the painful M2 stage, and it helps in the short term by reducing severity and speeding healing. The problem is that lesions come back often. Other topical choices, salicylic acid paste and polyurethane wound dressings, performed about as well as each other in some trials, which suggests non-antibiotic routes can cut antibiotic reliance, particularly in herds with frequent relapses.

Disinfection matters too. In the lab, 1% FAM30, 2% Virkon, and 2% sodium hypochlorite all stopped visible growth of BDD-associated treponemes. Field results depend on contact time, organic matter like manure, lesion depth, and biofilm-like organization, so disinfection has to come with cleaning and enough exposure.

On susceptibility, lab tests show many isolates are vulnerable to penicillin, ampicillin, erythromycin, and tetracycline-class drugs, with low minimum inhibitory concentrations across several beta-lactams, macrolides, and tetracyclines. Lab vulnerability does not guarantee a clinical cure, because biofilms, dead tissue, and poor topical contact blunt the effect. Worth noting: resistance-gene work has found tetracycline resistance genes such as tetQ and tetM inside the wider lesion microbiome, often in non-treponemal anaerobes. Repeated antibiotic use can therefore select for resistance across the whole community, not just in T. phagedenis.

Footbaths are a cornerstone of prevention in dairy herds. Common agents include copper sulfate, formaldehyde, glutaraldehyde, and potassium persulfate compounds. Their worth depends on the right concentration, a clean solution, cow flow, and frequency, because a contaminated footbath can itself become a reservoir for treponemes.

Hoof trimming, done with care, keeps hoof balance, removes damaged horn, and cuts the trauma that lets infection in. Done badly, it damages tissue and spreads bacteria on shared equipment. Disinfect trimming tools between every animal.

Nutrition and environment pull their weight as well. Wet floors, poor drainage, high stocking density, and manure buildup all raise exposure. Better surfaces, drainage, bedding, and hygiene lower transmission pressure. Zinc supplementation may support hoof quality and skin integrity, though it should be seen as supportive rather than a standalone fix.

A practical control mindset

The herds that win against BDD combine early detection, standardized M-stage recording, prompt treatment of active lesions, regular hoof hygiene, well-run footbaths, disinfection of trimming equipment, better housing, and, just as important, monitoring of chronic M4 and recurrent M4.1 lesions. Because chronic lesions can quietly hold infection even after acute cases clear, the aim is not only to heal what you can see but to cut environmental contamination and find the cows acting as reservoirs.

The short version

BDD is a polymicrobial, contagious hoof disease, and T. phagedenis is one of its most consistent and consequential members. It is an anaerobic, fussy spirochete whose motility, surface diversity, and immune meddling help lesions persist and recur. Lesions that look healed may still be inflamed, which is why recurrence and reinfection are routine. Diagnosis gets far stronger when clinical staging teams up with PCR/qPCR and FISH. Topical oxytetracycline helps short term but rarely stops recurrence, so control rests on integrated, herd-level management and disciplined hygiene. No widely validated vaccine exists yet, and resistance genes in the lesion microbiome argue for restrained, targeted antibiotic use.

For producers, the message is plain. Digital dermatitis is manageable, but only with steady, farm-wide effort instead of one-off treatments. Understanding the biology of T. phagedenis is the first step toward breaking the loop of lesions and relapse.